Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 1/2 6Phase 1 4Phase EARLY_PHASE1 1

Status

Completed 3Withdrawn 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Head & Neck 1Gynecologic 1Breast 1

Conditions

Prostatic Neoplasms 2Neoplasms 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 626pembrolizumab 505Paclitaxel 456Gemcitabine 439Carboplatin 437Cisplatin 420Radiotherapy 382fludarabine 367Nivolumab 340Docetaxel 278Bevacizumab 276Irinotecan 258Magnetic Resonance Spectroscopy 245Fluorouracil 229Dexamethasone 225Specimen Handling 223Capecitabine 218Rituximab 206Oxaliplatin 201Cytarabine 201Ipilimumab 198Temozolomide 197Biopsy 197fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 174Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Genistein × Clear all
NCT02075112 2019-12-06

Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck

Emory University

Phase 1 Completed
24 enrolled
Head & Neck

Head and Neck Neoplasms

NCT00099008 2013-05-21

Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women

UNC Lineberger Comprehensive Cancer Center

Phase 1 Completed
30 enrolled
BreastGynecologic

Breast Neoplasms, Endometrial Neoplasms

NCT00005827 2012-04-24

Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 1 Withdrawn
Genitourinary

Prostatic Neoplasms

NCT00001696 2008-03-04

A Pharmacokinetic Study of Genistein, a Tyrosine Kinase Inhibitor

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
15 enrolled
Genitourinary

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡